ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

Nav: ₹ 17.2759 ↑ 1.09%
[as on 1 October, 2025]

Nav chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -7.66% 1.09% 1.09% -0.41% -2.08% -4.33% 21.78%---

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.83% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.17%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology10.60%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology8.38%
Apollo Hospitals Enterprise LimitedHealthcare Services5.96%
Max Healthcare Institute LimitedHealthcare Services5.89%
Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology4.53%
Cohance Lifesciences LimitedPharmaceuticals & Biotechnology4.31%
Fortis Healthcare LimitedHealthcare Services3.87%
Aurobindo Pharma LimitedPharmaceuticals & Biotechnology3.43%
Aster DM Healthcare LimitedHealthcare Services3.30%
Lupin LimitedPharmaceuticals & Biotechnology3.01%
Mankind Pharma LimitedPharmaceuticals & Biotechnology2.97%
Alkem Laboratories LimitedPharmaceuticals & Biotechnology2.91%
Wockhardt LimitedPharmaceuticals & Biotechnology2.49%
Neuland Laboratories LimitedPharmaceuticals & Biotechnology2.36%
Abbott India LimitedPharmaceuticals & Biotechnology2.34%
Cipla LimitedPharmaceuticals & Biotechnology2.33%
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology2.02%
Healthcare Global Enterprises LimitedHealthcare Services1.87%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology1.65%
Sumitomo Chemical India LimitedFertilizers & Agrochemicals1.55%
Vijaya Diagnostic Centre LimitedHealthcare Services1.52%
FDC LimitedPharmaceuticals & Biotechnology1.43%
Rainbow Childrens Medicare LimitedHealthcare Services1.33%
Laurus Labs LimitedPharmaceuticals & Biotechnology1.33%
IPCA Laboratories LimitedPharmaceuticals & Biotechnology1.27%
SBI Life Insurance Company LimitedInsurance1.24%
Orchid Pharma LimitedPharmaceuticals & Biotechnology1.17%
Standard Glass Lining Technology LtdIndustrial Manufacturing1.05%
Onesource Specialty Pharma LimitedPharmaceuticals & Biotechnology1.04%
Sagility India LimitedIT - Services1.00%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.97%
Supriya Lifescience LimitedPharmaceuticals & Biotechnology0.96%
SRF LimitedChemicals & Petrochemicals0.94%
Shilpa Medicare LimitedPharmaceuticals & Biotechnology0.92%
Caplin Point Laboratories LimitedPharmaceuticals & Biotechnology0.91%
Linde India LimitedChemicals & Petrochemicals0.88%
Navin Fluorine International LimitedChemicals & Petrochemicals0.82%
Glenmark Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.78%
UPL LimitedFertilizers & Agrochemicals0.73%
Biocon LimitedPharmaceuticals & Biotechnology0.68%
Zydus Lifesciences LimitedPharmaceuticals & Biotechnology0.62%
Syngene International LimitedHealthcare Services0.47%

Debt

NameRatingWeight %
Portfolio data is as on date 31 August, 2025

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 17.2759 as on 1 October, 2025.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -7.66% as on 1 October, 2025.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -4.33% as on 1 October, 2025.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 21.78% as on 1 October, 2025.